As my Pfizer-BioNTech ‘placebo’ report from last July has for some reason just gone viral again, this is a good time to address an important detail which I did not cover in the original report and which was neglected in the sometimes heated discussion which followed. ‘Placebo’ does not necessarily mean saline solution. Placebo in this context could just as well mean ‘no mRNA’, i.e., a solution containing all the ingredients of the drug except the mRNA which is supposed to be packed into the lipid nanoparticles which serve as delivery system in the BioNTech platform. The lipids are empty: they have nothing to deliver. The ‘active drug substance’, the mRNA, is missing.
Although they did not come right out and say it, this appears in fact to be what the German chemistry professors whom I was citing had in mind. The focus of my report was not the now famous Danish batch variability study, which found that different batches of the Pfizer-BioNTech vaccine were associated with wildly different levels of toxicity, breaking down into three large ‘blue’, ‘green’ and ‘yellow’ groups, as represented in the below graph.
The focus of my report was the discovery by the German professors that all but one of the ‘yellow’ batches, which are almost entirely innocuous per the Danish data, had not been subject to quality control testing by the agency responsible for batch release throughout the EU, namely, Germany’s own Paul Ehrlich Institute (PEI).